$MFIN
MEDALLION FINANCIAL CORP Stock $mfin

$mfin Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024027942 Filed on March 07, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$67.07M		$251.0M
YoY Change	20.1%		27.68%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.381M	$1.343M	$5.243M
YoY Change	6.23%	63.58%	0.27%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$19.15M		$62.95M
YoY Change	56.48%		73.96%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$17.89M	$22.16M	$86.04M
YoY Change	-23.05%	12.79%	26.8%
Income Tax	$6.358M	$6.328M	$24.91M
% Of Pretax Income	35.53%	28.56%	28.95%
Net Earnings	$10.02M	$14.32M	$55.08M
YoY Change	-34.74%	9.61%	25.64%
Net Earnings / Revenue	14.95%		21.94%
Basic Earnings Per Share	$0.44		$2.45
Diluted Earnings Per Share	$0.42	$0.60	$2.37
COMMON SHARES
Basic Shares Outstanding	23.48M	23.36M	22.51M
Diluted Shares Outstanding	23.77M		23.25M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$107.8M	$106.9M
YoY Change	55.56%	30.87%
Cash & Equivalents	$54.78M	$52.59M
Short-Term Investments	$53.04M	$54.28M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$14.02M	$14.08M	$14.08M
YoY Change	4.65%	6.9%	6.9%
Goodwill	$150.8M	$150.8M
YoY Change	0.0%	0.0%
Intangibles	$20.23M	$20.59M
YoY Change	-6.67%	-6.55%
Long-Term Investments	$69.41M	$65.71M	$65.71M
YoY Change	551.57%	538.41%	538.41%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.619B	$2.588B	$2.588B
YoY Change	11.36%	14.51%	14.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$32.26M	$37.63M	$37.63M
YoY Change	10.67%	47.41%	47.41%
Accrued Expenses	$6.710M	$7.019M	$7.019M
YoY Change	-35.37%	-34.08%	-34.08%
Deferred Revenue
YoY Change
Short-Term Debt	$32.50M	$8.000M	$8.000M
YoY Change	-15.58%	60.0%	60.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$71.47M	$52.64M	$52.64M
YoY Change	-9.7%	45.54%	45.54%
LONG-TERM LIABILITIES
Long-Term Debt	$225.6M	$235.5M	$235.5M
YoY Change	28.26%	9.9%	9.9%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$225.6M	$235.5M	$235.5M
YoY Change	28.26%	9.9%	9.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$71.47M	$52.64M	$52.64M
Total Long-Term Liabilities	$225.6M	$235.5M	$235.5M
Total Liabilities	$2.270B	$2.245B	$2.245B
YoY Change	14.83%	18.82%	14.64%
SHAREHOLDERS EQUITY
Retained Earnings	$111.6M	$103.9M
YoY Change	58.85%	55.81%
Common Stock	$289.0M	$288.3M
YoY Change	1.57%	1.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$47.66M	$45.54M
YoY Change	4.67%	0.0%
Treasury Stock Shares
Shareholders Equity	$349.0M	$343.0M	$343.0M
YoY Change
Total Liabilities & Shareholders Equity	$2.619B	$2.588B	$2.588B
YoY Change	11.36%	14.51%	14.51%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$10.02M	$14.32M	$55.08M
YoY Change	-34.74%	9.61%	25.64%
Depreciation, Depletion And Amortization	$1.381M	$1.343M	$5.243M
YoY Change	6.23%	63.58%	0.27%
Cash From Operating Activities	$32.26M	$19.66M	$113.8M
YoY Change	10.74%	-33.9%	4.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$32.91M	-$12.50M	-$340.7M
YoY Change	-59.6%	-81.69%	-24.12%
Cash From Investing Activities	-$32.91M	-$12.50M	-$340.7M
YoY Change	-59.6%	-81.69%	-24.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	19.93M	15.08M	271.2M
YoY Change	-74.8%	-67.14%	-15.62%
NET CHANGE
Cash From Operating Activities	32.26M	19.66M	113.8M
Cash From Investing Activities	-32.91M	-12.50M	-340.7M
Cash From Financing Activities	19.93M	15.08M	271.2M
Net Change In Cash	19.28M	22.25M	44.25M
YoY Change	-28.02%	200.8%	-334.28%
FREE CASH FLOW
Cash From Operating Activities	$32.26M	$19.66M	$113.8M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001000209
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#EquitySecuritiesMember
CY2023	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2033-12-31
CY2023Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2028-09-30
CY2021Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2026-02-28
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.medallion.com/20231231#PropertyEquipmentAndRightOfUseAssetNet
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://www.medallion.com/20231231#PropertyEquipmentAndRightOfUseAssetNet
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P0Y
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-37747
CY2023	dei	Entity Registrant Name EntityRegistrantName	MEDALLION FINANCIAL CORP
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3291176
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	437 MADISON AVENUE, 38th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2023	dei	City Area Code CityAreaCode	212
CY2023	dei	Local Phone Number LocalPhoneNumber	328-2100
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	MFIN
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	146115624000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23483564
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	mfin	Rule10 B51 Arr Modified Flag Rule10B51ArrModifiedFlag	false
CY2023Q4	mfin	Non Rule10 B51 Arr Modified Flag NonRule10B51ArrModifiedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	339
CY2023	dei	Auditor Name AuditorName	Mazars USA LLP
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	52591000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33172000
CY2023Q4	us-gaap	Federal Funds Sold FederalFundsSold	97254000
CY2022Q4	us-gaap	Federal Funds Sold FederalFundsSold	72426000
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	54282000
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	48492000
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	11430000
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	10293000
CY2023Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2215886000
CY2022Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1916953000
CY2023Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	84235000
CY2022Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	63845000
CY2023Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	2131651000
CY2022Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1853108000
CY2023Q4	us-gaap	Goodwill Goodwill	150803000
CY2022Q4	us-gaap	Goodwill Goodwill	150803000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20591000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22035000
CY2023Q4	mfin	Property Equipment And Right Of Use Asset Net PropertyEquipmentAndRightOfUseAssetNet	14076000
CY2022Q4	mfin	Property Equipment And Right Of Use Asset Net PropertyEquipmentAndRightOfUseAssetNet	13168000
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	13538000
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	12613000
CY2023Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	11772000
CY2022Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	21819000
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	671000
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	2095000
CY2023Q4	us-gaap	Other Assets OtherAssets	29168000
CY2022Q4	us-gaap	Other Assets OtherAssets	19855000
CY2023Q4	us-gaap	Assets Assets	2587827000
CY2022Q4	us-gaap	Assets Assets	2259879000
CY2023Q4	us-gaap	Deposits Deposits	1866657000
CY2022Q4	us-gaap	Deposits Deposits	1607110000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	235544000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	214320000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	21207000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	26753000
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	8000000
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5000000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7019000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8408000
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6822000
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	4790000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	30804000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	22974000
CY2023Q4	us-gaap	Liabilities Liabilities	2176053000
CY2022Q4	us-gaap	Liabilities Liabilities	1889355000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29051800
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28663827
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	291000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	287000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	288046000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	283663000
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5602154
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5602154
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	45538000
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	45538000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3696000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3349000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	103883000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	66673000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	342986000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	301736000
CY2023Q4	us-gaap	Minority Interest MinorityInterest	68788000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	68788000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	411774000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	370524000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2587827000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2259879000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23449646
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23061673
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.63
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	13.08
CY2023Q4	mfin	Loan Foreclosure Collateral Sale To Third Party LoanForeclosureCollateralSaleToThirdParty	6200000
CY2022Q4	mfin	Loan Foreclosure Collateral Sale To Third Party LoanForeclosureCollateralSaleToThirdParty	7500000
CY2023Q4	mfin	Short Term Lease Liabilities ShortTermLeaseLiabilities	2500000
CY2022Q4	mfin	Short Term Lease Liabilities ShortTermLeaseLiabilities	2200000
CY2023	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	244829000
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	195074000
CY2021	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	157990000
CY2023	mfin	Interest And Dividends On Investment Securities InterestAndDividendsOnInvestmentSecurities	6211000
CY2022	mfin	Interest And Dividends On Investment Securities InterestAndDividendsOnInvestmentSecurities	1547000
CY2021	mfin	Interest And Dividends On Investment Securities InterestAndDividendsOnInvestmentSecurities	976000
CY2023	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	251040000
CY2022	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	196621000
CY2021	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	158966000
CY2023	us-gaap	Interest Expense Deposits InterestExpenseDeposits	47780000
CY2022	us-gaap	Interest Expense Deposits InterestExpenseDeposits	22666000
CY2021	us-gaap	Interest Expense Deposits InterestExpenseDeposits	17543000
CY2023	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	12670000
CY2022	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	13387000
CY2021	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	12907000
CY2023	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	2496000
CY2022	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	132000
CY2021	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	690000
CY2023	us-gaap	Interest Expense InterestExpense	62946000
CY2022	us-gaap	Interest Expense InterestExpense	36185000
CY2021	us-gaap	Interest Expense InterestExpense	31140000
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	188094000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	160436000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	127826000
CY2023	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	37810000
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	30059000
CY2021	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4622000
CY2023	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	150284000
CY2022	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	130377000
CY2021	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	123204000
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	5178000
CY2022	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	2779000
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	17379000
CY2023	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	4992000
CY2022	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	5448000
CY2021	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1788000
CY2023	mfin	Writedown Of Loan Collateral In Process Of Foreclosure WritedownOfLoanCollateralInProcessOfForeclosure	1696000
CY2022	mfin	Writedown Of Loan Collateral In Process Of Foreclosure WritedownOfLoanCollateralInProcessOfForeclosure	657000
CY2021	mfin	Writedown Of Loan Collateral In Process Of Foreclosure WritedownOfLoanCollateralInProcessOfForeclosure	5592000
CY2023	mfin	Income From Sponsorship And Race Winnings IncomeFromSponsorshipAndRaceWinnings	0
CY2022	mfin	Income From Sponsorship And Race Winnings IncomeFromSponsorshipAndRaceWinnings	0
CY2021	mfin	Income From Sponsorship And Race Winnings IncomeFromSponsorshipAndRaceWinnings	12567000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4626000
CY2023	us-gaap	Noninterest Income Other NoninterestIncomeOther	2846000
CY2022	us-gaap	Noninterest Income Other NoninterestIncomeOther	1956000
CY2021	us-gaap	Noninterest Income Other NoninterestIncomeOther	798000
CY2023	us-gaap	Noninterest Income NoninterestIncome	11320000
CY2022	us-gaap	Noninterest Income NoninterestIncome	9526000
CY2021	us-gaap	Noninterest Income NoninterestIncome	31566000
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	37562000
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	31130000
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	31591000
CY2023	mfin	Loan Servicing Fee LoanServicingFee	9543000
CY2022	mfin	Loan Servicing Fee LoanServicingFee	8371000
CY2021	mfin	Loan Servicing Fee LoanServicingFee	7013000
CY2023	mfin	Collection Costs CollectionCosts	6000000
CY2022	mfin	Collection Costs CollectionCosts	5314000
CY2021	mfin	Collection Costs CollectionCosts	5279000
CY2023	us-gaap	Professional Fees ProfessionalFees	5886000
CY2022	us-gaap	Professional Fees ProfessionalFees	13054000
CY2021	us-gaap	Professional Fees ProfessionalFees	5311000
CY2023	mfin	Regulatory Fees RegulatoryFees	3194000
CY2022	mfin	Regulatory Fees RegulatoryFees	2418000
CY2021	mfin	Regulatory Fees RegulatoryFees	1872000
CY2023	mfin	Lease And Rental Expense1 LeaseAndRentalExpense1	2472000
CY2022	mfin	Lease And Rental Expense1 LeaseAndRentalExpense1	2378000
CY2021	mfin	Lease And Rental Expense1 LeaseAndRentalExpense1	2454000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1445000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1445000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1445000
CY2023	mfin	Race Team Related Expense RaceTeamRelatedExpense	0
CY2022	mfin	Race Team Related Expense RaceTeamRelatedExpense	0
CY2021	mfin	Race Team Related Expense RaceTeamRelatedExpense	9559000
CY2023	us-gaap	Other Noninterest Expense OtherNoninterestExpense	9466000
CY2022	us-gaap	Other Noninterest Expense OtherNoninterestExpense	7943000
CY2021	us-gaap	Other Noninterest Expense OtherNoninterestExpense	8375000
CY2023	us-gaap	Noninterest Expense NoninterestExpense	75568000
CY2022	us-gaap	Noninterest Expense NoninterestExpense	72053000
CY2021	us-gaap	Noninterest Expense NoninterestExpense	72899000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	86036000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	67850000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	81871000
CY2023	mfin	Income Tax Expense Benefit On Net Investment IncomeTaxExpenseBenefitOnNetInvestment	24910000
CY2022	mfin	Income Tax Expense Benefit On Net Investment IncomeTaxExpenseBenefitOnNetInvestment	17963000
CY2021	mfin	Income Tax Expense Benefit On Net Investment IncomeTaxExpenseBenefitOnNetInvestment	24217000
CY2023	mfin	Net Investment Income Loss After Taxes NetInvestmentIncomeLossAfterTaxes	61126000
CY2022	mfin	Net Investment Income Loss After Taxes NetInvestmentIncomeLossAfterTaxes	49887000
CY2021	mfin	Net Investment Income Loss After Taxes NetInvestmentIncomeLossAfterTaxes	57654000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6047000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6047000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3546000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	55079000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	43840000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	54108000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.45
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.86
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.2
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.37
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.83
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.17
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22510435
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23583049
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24599804
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23248323
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23927342
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24943169
CY2023	us-gaap	Paid In Kind Interest PaidInKindInterest	1600000
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	700000
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	800000
CY2023	mfin	Average Borrowings Outstanding AverageBorrowingsOutstanding	2000000000
CY2022	mfin	Average Borrowings Outstanding AverageBorrowingsOutstanding	1700000000
CY2021	mfin	Average Borrowings Outstanding AverageBorrowingsOutstanding	1400000000
CY2023	mfin	Weighted Average Cost Of Borrowings WeightedAverageCostOfBorrowings	0.0316
CY2022	mfin	Weighted Average Cost Of Borrowings WeightedAverageCostOfBorrowings	0.0217
CY2021	mfin	Weighted Average Cost Of Borrowings WeightedAverageCostOfBorrowings	0.0228
CY2023	us-gaap	Profit Loss ProfitLoss	61126000
CY2022	us-gaap	Profit Loss ProfitLoss	49887000
CY2021	us-gaap	Profit Loss ProfitLoss	57654000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-347000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4383000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-978000
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	60779000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	45504000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	56676000
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	6047000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	6047000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3546000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	54732000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	39457000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	53130000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	304561000
CY2021	us-gaap	Profit Loss ProfitLoss	57654000
CY2021	mfin	Distribution To Noncontrolling Interest DistributionToNoncontrollingInterest	-6516000
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-1395000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2261000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	241000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-978000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	355828000
CY2022	us-gaap	Profit Loss ProfitLoss	49887000
CY2022	mfin	Distribution To Noncontrolling Interest DistributionToNoncontrollingInterest	-6047000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3476000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	155000
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	20619000
CY2022	us-gaap	Dividends Common Stock DividendsCommonStock	7773000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4383000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	370524000
CY2023	us-gaap	Profit Loss ProfitLoss	61126000
CY2023	mfin	Distribution To Noncontrolling Interest DistributionToNoncontrollingInterest	-6047000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4713000
CY2023	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-768000
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	442000
CY2023	us-gaap	Dividends Common Stock DividendsCommonStock	7934000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-347000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	411774000
CY2023	us-gaap	Profit Loss ProfitLoss	61126000
CY2022	us-gaap	Profit Loss ProfitLoss	49887000
CY2021	us-gaap	Profit Loss ProfitLoss	57654000
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	37810000
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	30059000
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	4622000
CY2023	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1636000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	464448000
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	11573000
CY2022	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	724000
CY2021	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	814000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5243000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5229000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6519000
CY2023	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-9588000
CY2022	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-8707000
CY2021	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-7996000
CY2023	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-345000
CY2022	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	7281000
CY2021	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	18327000
CY2023	mfin	Net Change In Loan Collateral In Process Of Foreclosure NetChangeInLoanCollateralInProcessOfForeclosure	-10597000
CY2022	mfin	Net Change In Loan Collateral In Process Of Foreclosure NetChangeInLoanCollateralInProcessOfForeclosure	-5738000
CY2021	mfin	Net Change In Loan Collateral In Process Of Foreclosure NetChangeInLoanCollateralInProcessOfForeclosure	-8966000
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	5178000
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	2779000
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	17380000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	4713000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3476000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2261000
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	4626000
CY2023	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	925000
CY2022	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	1992000
CY2021	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	283000
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	715000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15470000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3919000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5354000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6209000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6382000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2694000
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	2032000
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1395000
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-1141000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	113764000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	108740000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	78726000
CY2023	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	975391000
CY2022	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	1000785000
CY2021	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	760790000
CY2023	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	616193000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	535067000
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	20713000
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	19354000
CY2023	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
CY2022	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0
CY2021	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	17676000
CY2023	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	9444000
CY2022	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	14762000
CY2021	us-gaap	Proceeds From Sale And Collection Of Receivables ProceedsFromSaleAndCollectionOfReceivables	35647000
CY2023	mfin	Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure	20631000
CY2022	mfin	Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure	22664000
CY2021	mfin	Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure	24052000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-340696000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-449005000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-238321000
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	975175000
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	839104000
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	805577000
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	689920000
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	483671000
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	627263000
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20619000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7703000
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7543000
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0
CY2023	mfin	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	6047000
CY2022	mfin	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	6047000
CY2021	mfin	Distributions To Noncontrolling Interests DistributionsToNoncontrollingInterests	6516000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	768000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	442000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	155000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	241000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	271179000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	321379000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	172039000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	44247000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18886000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12444000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	105598000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	124484000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	112040000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	149845000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	105598000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	124484000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	57509000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	31976000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	29867000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	25102000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8848000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5479000
CY2023	mfin	Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure	21181000
CY2022	mfin	Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure	12791000
CY2021	mfin	Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure	15888000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S., or GAAP, requires management to make estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. Accounting estimates and assumptions are those that management considers to be the most critical to an understanding of the consolidated financial statements because they inherently involve significant judgments and uncertainties. All of these estimates reflect management’s best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions change, it is reasonably possible that the judgments and estimates could change, which may result in future impairments of loans and loan collateral in process of foreclosure, goodwill and intangible assets, and investments, among other effects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	1300000
CY2023Q4	mfin	Non Marketable Securities NonMarketableSecurities	11400000
CY2022Q4	mfin	Non Marketable Securities NonMarketableSecurities	10300000
CY2023Q4	mfin	Impact Of Equity Investment ImpactOfEquityInvestment	3500000
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	2000000
CY2023Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1700000
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	1700000
CY2023	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	24000
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-226000
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-50000
CY2023	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0
CY2022	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0
CY2021	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	0
CY2023	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	24000
CY2022	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-226000
CY2021	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-50000
CY2022	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	100000
CY2021	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	100000
CY2023	mfin	Deferred Loan Origination Costs DeferredLoanOriginationCosts	40000000
CY2022	mfin	Deferred Loan Origination Costs DeferredLoanOriginationCosts	34900000
CY2023	mfin	Amortization Of Loan Origination Fees Net AmortizationOfLoanOriginationFeesNet	8300000
CY2022	mfin	Amortization Of Loan Origination Fees Net AmortizationOfLoanOriginationFeesNet	8700000
CY2021	mfin	Amortization Of Loan Origination Fees Net AmortizationOfLoanOriginationFeesNet	8000000
CY2023Q1	mfin	Loans Charged Off LoansChargedOff	2500000
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	79500
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	14000000
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	19500000
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	63845000
CY2023Q4	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P20Y
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20600000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22000000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20591000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22035000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	400
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	400000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	300000
CY2023	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	3100000
CY2022	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	2600000
CY2021	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	2400000
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	8500000
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	7000000
CY2023	mfin	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	55079000
CY2022	mfin	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	43840000
CY2021	mfin	Net Increase Decrease In Net Assets Resulting From Operations NetIncreaseDecreaseInNetAssetsResultingFromOperations	54108000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22510435
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23583049
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24599804
CY2023	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	461098
CY2022	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	276469
CY2021	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	250763
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	142216
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	67825
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	92602
CY2023	mfin	Incremental Common Shares Attributable To Dilutive Effect Of Performance Share Units IncrementalCommonSharesAttributableToDilutiveEffectOfPerformanceShareUnits	134574
CY2022	mfin	Incremental Common Shares Attributable To Dilutive Effect Of Performance Share Units IncrementalCommonSharesAttributableToDilutiveEffectOfPerformanceShareUnits	0
CY2021	mfin	Incremental Common Shares Attributable To Dilutive Effect Of Performance Share Units IncrementalCommonSharesAttributableToDilutiveEffectOfPerformanceShareUnits	0
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23248323
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23927342
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24943169
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.45
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.86
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.2
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.37
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.83
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.17
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	92310
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	347963
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	421190
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	317398
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4700000
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3500000
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2300000
CY2023	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	0.2
CY2022	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	0.15
CY2021	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	0.09
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	5000000
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P9M
CY2023Q4	mfin	Tier One Leverage Capital Required For Capital Adequacy To Total Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToTotalAssets	0.15
CY2023Q4	mfin	Tier One Leverage Capital Ratio TierOneLeverageCapitalRatio	0.162
CY2023Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	293774000
CY2022Q4	us-gaap	Common Equity Tier One Capital CommonEquityTierOneCapital	242049000
CY2023Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	362561000
CY2022Q4	us-gaap	Tier One Risk Based Capital TierOneRiskBasedCapital	310837000
CY2023Q4	us-gaap	Capital Capital	390153000
CY2022Q4	us-gaap	Capital Capital	334913000
CY2023	mfin	Average Assets AverageAssets	2232816000
CY2022	mfin	Average Assets AverageAssets	1917904000
CY2023Q4	us-gaap	Risk Weighted Assets RiskWeightedAssets	2155641000
CY2022Q4	us-gaap	Risk Weighted Assets RiskWeightedAssets	1888530000
CY2023Q4	us-gaap	Tier One Leverage Capital Required For Capital Adequacy To Average Assets TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets	0.04
CY2023Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.05
CY2023Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.162
CY2022Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.162
CY2023Q4	mfin	Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.07
CY2023Q4	mfin	Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.065
CY2023Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.136
CY2022Q4	us-gaap	Common Equity Tier One Capital Ratio CommonEquityTierOneCapitalRatio	0.128
CY2023	mfin	Tier One Risk Based Capital Required For Capital Adequacy With Buffer To Risk Weighted Assets TierOneRiskBasedCapitalRequiredForCapitalAdequacyWithBufferToRiskWeightedAssets	0.085
CY2023Q4	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.08
CY2023Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.168
CY2022Q4	us-gaap	Tier One Risk Based Capital To Risk Weighted Assets TierOneRiskBasedCapitalToRiskWeightedAssets	0.165
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	60573000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	54282000
CY2023Q4	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.105
CY2023Q4	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.10
CY2023Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.181
CY2022Q4	us-gaap	Capital To Risk Weighted Assets CapitalToRiskWeightedAssets	0.177
CY2023	mfin	Tier One Capital Conversation Buffer TierOneCapitalConversationBuffer	0.025
CY2022	mfin	Tier One Capital Conversation Buffer TierOneCapitalConversationBuffer	0.025
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to prior year balances to conform with the current year presentation. These reclassifications have no effect on the previously reported results of operations.</span></p>
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	60573000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	21000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	6312000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	54282000
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	54301000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	5822000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	48492000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	2395000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2336000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	7313000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	7049000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	8833000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	7808000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	42032000
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	37089000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	282000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	10636000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	6030000
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	43509000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1017000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	16949000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4805000
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	29525000
CY2023Q4	mfin	Number Of Securities NumberOfSecurities	60
CY2022Q4	mfin	Number Of Securities NumberOfSecurities	57
CY2022Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	63845000
CY2021Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	50166000
CY2023	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	67668000
CY2022	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	39845000
CY2023	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	36536000
CY2022	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	23465000
CY2023	us-gaap	Allowance For Loan And Lease Losses Writeoffs Net AllowanceForLoanAndLeaseLossesWriteoffsNet	31132000
CY2022	us-gaap	Allowance For Loan And Lease Losses Writeoffs Net AllowanceForLoanAndLeaseLossesWriteoffsNet	16380000
CY2023	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	37810000
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	30059000
CY2023Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	84235000
CY2022Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	63845000
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYearWriteoff	5332000
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYearWriteoff	24522000
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYearWriteoff	13638000
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff	5817000
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYearWriteoff	6336000
CY2023	us-gaap	Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year Writeoff FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYearWriteoff	12023000
CY2023	mfin	Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Write Off1 FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteOff1	67668000
CY2023Q4	mfin	Impaired Financing Receivables With Related Allowance Related Allowance ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance	3890000
CY2022Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	32550000
CY2022Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	33754000
CY2022Q4	mfin	Impaired Financing Receivables With Related Allowance Related Allowance ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance	10806000
CY2023Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	84235000
CY2023Q4	mfin	Percentage Of Allowance For Loan Losses PercentageOfAllowanceForLoanLosses	1
CY2023Q4	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans	0.038
CY2023Q4	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual	3.2431
CY2022Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	63845000
CY2022Q4	mfin	Percentage Of Allowance For Loan Losses PercentageOfAllowanceForLoanLosses	1
CY2022Q4	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans	0.0333
CY2022Q4	mfin	Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual	1.9869
CY2023Q4	us-gaap	Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest	25974000
CY2022Q4	us-gaap	Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest	32133000
CY2021Q4	us-gaap	Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest	35571000
CY2023	mfin	Interest Income Foregone On Non Accrual Loans InterestIncomeForegoneOnNonAccrualLoans	928000
CY2022	mfin	Interest Income Foregone On Non Accrual Loans InterestIncomeForegoneOnNonAccrualLoans	1267000
CY2021	mfin	Interest Income Foregone On Non Accrual Loans InterestIncomeForegoneOnNonAccrualLoans	1620000
CY2023	mfin	Amount Of Foregone Interest Applied To Principal AmountOfForegoneInterestAppliedToPrincipal	238000
CY2022	mfin	Amount Of Foregone Interest Applied To Principal AmountOfForegoneInterestAppliedToPrincipal	375000
CY2021	mfin	Amount Of Foregone Interest Applied To Principal AmountOfForegoneInterestAppliedToPrincipal	432000
CY2023	mfin	Interest Foregone Life To Date InterestForegoneLifeToDate	2119000
CY2022	mfin	Interest Foregone Life To Date InterestForegoneLifeToDate	2419000
CY2021	mfin	Interest Foregone Life To Date InterestForegoneLifeToDate	3623000
CY2023	mfin	Amount Of Foregone Interest Applied To Principal Life To Date AmountOfForegoneInterestAppliedToPrincipalLifeToDate	822000
CY2022	mfin	Amount Of Foregone Interest Applied To Principal Life To Date AmountOfForegoneInterestAppliedToPrincipalLifeToDate	1204000
CY2021	mfin	Amount Of Foregone Interest Applied To Principal Life To Date AmountOfForegoneInterestAppliedToPrincipalLifeToDate	942000
CY2023Q4	us-gaap	Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans	0.012
CY2022Q4	us-gaap	Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans	0.017
CY2021Q4	us-gaap	Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans	0.024
CY2023Q4	mfin	Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans	3.243
CY2022Q4	mfin	Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans	1.987
CY2021Q4	mfin	Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans	1.41
CY2023Q4	us-gaap	Loans And Leases Receivable Loans In Process LoansAndLeasesReceivableLoansInProcess	2215886000
CY2023	mfin	Loans And Leases Receivable Non Performing Percentage LoansAndLeasesReceivableNonPerformingPercentage	0.0117
CY2022Q4	us-gaap	Loans And Leases Receivable Loans In Process LoansAndLeasesReceivableLoansInProcess	1916953000
CY2022	mfin	Loans And Leases Receivable Non Performing Percentage LoansAndLeasesReceivableNonPerformingPercentage	0.017
CY2023Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	25974000
CY2023Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	26796000
CY2023	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	22405000
CY2023	mfin	Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod	17000
CY2022	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	39007000
CY2022	mfin	Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod	405000
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	81013000
CY2023Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	2176412000
CY2023Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0
CY2023	mfin	Capitalized Loan Origination Costs CapitalizedLoanOriginationCosts	40000000
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	57618000
CY2022Q4	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	1882585000
CY2022Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0
CY2022	mfin	Capitalized Loan Origination Costs CapitalizedLoanOriginationCosts	34900000
CY2023Q4	mfin	Loan To Value Ratio LoanToValueRatio	1.83
CY2022Q4	mfin	Loan To Value Ratio LoanToValueRatio	3.39
CY2022Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	21819000
CY2023	mfin	Loan In Process Of Foreclosure Loans Transfer LoanInProcessOfForeclosureLoansTransfer	21181000
CY2023	mfin	Loan In Process Of Foreclosure Loan Sales LoanInProcessOfForeclosureLoanSales	-8590000
CY2023	mfin	Loan In Process Of Foreclosure Loans Cash Payment Received LoanInProcessOfForeclosureLoansCashPaymentReceived	-12041000
CY2023	mfin	Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments LoanInProcessOfForeclosureLoansCollateralValuationAdjustments	-10597000
CY2023Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	11772000
CY2021Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	37430000
CY2022	mfin	Loan In Process Of Foreclosure Loans Transfer LoanInProcessOfForeclosureLoansTransfer	12791000
CY2022	mfin	Loan In Process Of Foreclosure Loan Sales LoanInProcessOfForeclosureLoanSales	-10375000
CY2022	mfin	Loan In Process Of Foreclosure Loans Cash Payment Received LoanInProcessOfForeclosureLoansCashPaymentReceived	-12289000
CY2022	mfin	Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments LoanInProcessOfForeclosureLoansCollateralValuationAdjustments	-5738000
CY2022Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	21819000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	686846000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	547405000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	370748000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	240208000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	187482000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	84500000
CY2023Q4	mfin	Debt Long Term And Short Term Funds Borrowed Amount DebtLongTermAndShortTermFundsBorrowedAmount	2117189000
CY2022Q4	mfin	Debt Long Term And Short Term Funds Borrowed Amount DebtLongTermAndShortTermFundsBorrowedAmount	1832184000
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.035
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	8500000
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	7000000
CY2023Q4	mfin	Reserve Deposits ReserveDeposits	1500000
CY2022Q4	mfin	Reserve Deposits ReserveDeposits	1300000
CY2023Q4	mfin	Listing Services Deposits From Other Financial Institutions ListingServicesDepositsFromOtherFinancialInstitutions	11800000
CY2022Q4	mfin	Listing Services Deposits From Other Financial Institutions ListingServicesDepositsFromOtherFinancialInstitutions	12400000
CY2023Q4	us-gaap	Deposits Retail DepositsRetail	14900000
CY2023Q4	us-gaap	Contractual Maturities Time Deposits100000 Or More Three Months Or Less ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsOrLess	191715000
CY2023Q4	us-gaap	Contractual Maturities Time Deposits100000 Or More Three Months Through Six Months ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsThroughSixMonths	190494000
CY2023Q4	us-gaap	Contractual Maturities Time Deposits100000 Or More Six Months Through12 Months ContractualMaturitiesTimeDeposits100000OrMoreSixMonthsThrough12Months	296637000
CY2023Q4	us-gaap	Contractual Maturities Time Deposits100000 Or More After12 Months ContractualMaturitiesTimeDeposits100000OrMoreAfter12Months	1190593000
CY2023Q4	us-gaap	Time Deposits100000 Or More TimeDeposits100000OrMore	1869439000
CY2023Q4	mfin	Collateral Deposits CollateralDeposits	1500000
CY2023Q4	us-gaap	Time Deposits TimeDeposits	1870939000
CY2019Q3	us-gaap	Notes Payable NotesPayable	6000000
CY2007Q4	us-gaap	Payments For Repurchase Of Trust Preferred Securities PaymentsForRepurchaseOfTrustPreferredSecurities	2000000
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	2390000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2216000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	2287000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	2472000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2378000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	2454000
CY2023	mfin	Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	-226000
CY2022	mfin	Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	-187000
CY2021	mfin	Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	-118000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8785000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9723000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2472000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2239000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7019000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8408000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9491000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	10647000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0547
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0566
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2536000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2546000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2567000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1342000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	573000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1139000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10703000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1212000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9491000
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	43034000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	43397000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	13032000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	9945000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3802000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3730000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1565000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	0
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1833000
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-222000
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	-811000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	6976000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	3819000
CY2023Q4	mfin	Deferred Tax Liabilities Unrealized Loss On Other Investments DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments	-1877000
CY2022Q4	mfin	Deferred Tax Liabilities Unrealized Loss On Other Investments DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments	-1445000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	17347000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	24458000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3860000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2295000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	21207000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	26753000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	18634000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5213000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3550000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6014000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	560000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1563000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-52000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	8090000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	13686000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	314000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4100000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	5418000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24910000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17963000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24217000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	18068000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	14249000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	17193000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3534000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2787000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3363000
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	23745
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.51
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1061849
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies State And Local IncomeTaxReconciliationTaxContingenciesStateAndLocal	1691000
CY2023	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	0
CY2022	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	0
CY2021	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	628000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2024000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1987000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	178000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-59000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-249000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	587000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24910000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17963000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24217000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	959522
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	697647
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0097
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.5398
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	951669
CY2020Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2020Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	12.55
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.41
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	317398
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.79
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	113310
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.64
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	44070
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.58
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1111687
CY2021Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2021Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	12.55
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.41
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022	mfin	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	26093
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	7.08
CY2022Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2022Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	9.38
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.51
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2023	mfin	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	33382
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.8
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	68945
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	6.44
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	959522
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit	2.14
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit	9.38
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.51
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	320922
CY2021Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit	2.14
CY2021Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit	12.55
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.53
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	548426
CY2022Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit	2.14
CY2022Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit	9.38
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.51
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	697647
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit	2.14
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit	9.38
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.51
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	200000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3200000
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2300000
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M24D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	513423
CY2022Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit	4.89
CY2022Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit	7.25
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.52
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	3336
CY2022	mfin	Interest Expense Net InterestExpenseNet	36185000
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	160436000
CY2022	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	30059000
CY2022	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	130377000
CY2022	us-gaap	Other Income OtherIncome	9526000
CY2023	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareLowerRangeLimit	4.89
CY2023	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit	7.25
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	5.51
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	248212
CY2023	mfin	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeLowerRangeLimit	4.89
CY2023	mfin	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit	7.25
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	6.55
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	261875
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit	4.89
CY2023Q4	mfin	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit	7.25
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	6.49
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	400000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	300000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	100000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	160595
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	5
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2023	mfin	Number Of Non Operating Segments NumberOfNonOperatingSegments	1
CY2023	mfin	Interest Income Expense Operating InterestIncomeExpenseOperating	251040000
CY2023	mfin	Interest Expense Net InterestExpenseNet	62946000
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	188094000
CY2023	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	37810000
CY2023	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	150284000
CY2023	us-gaap	Other Income OtherIncome	11320000
CY2023	mfin	Non Interest Expense Income NonInterestExpenseIncome	75568000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	86036000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24910000
CY2023	us-gaap	Profit Loss ProfitLoss	61126000
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6047000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	55079000
CY2023Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2215886000
CY2023Q4	us-gaap	Assets Assets	2587827000
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	2118690000
CY2023	mfin	Return On Average Assets Percentage ReturnOnAverageAssetsPercentage	0.0251
CY2023	mfin	Percentage Of Return On Average Stockholders Equity PercentageOfReturnOnAverageStockholdersEquity	0.1733
CY2023	mfin	Percentage Of Return On Average Equity PercentageOfReturnOnAverageEquity	0.1579
CY2023	mfin	Interest Yield InterestYield	0.1119
CY2023	mfin	Net Interest Margin NetInterestMargin	0.0838
CY2023	mfin	Net Interest Margin Net Of Allowance Percentage NetInterestMarginNetOfAllowancePercentage	0.0868
CY2023	mfin	Reserve Coverage Ratio ReserveCoverageRatio	0.038
CY2023	mfin	Delinquency Status DelinquencyStatus	0.0077
CY2023	mfin	Chargeoffs To Loans Percentage ChargeoffsToLoansPercentage	0.0148
CY2022	mfin	Interest Income Expense Operating InterestIncomeExpenseOperating	196621000
CY2022	mfin	Non Interest Expense Income NonInterestExpenseIncome	72053000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	67850000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17963000
CY2022	us-gaap	Profit Loss ProfitLoss	49887000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	6047000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	43840000
CY2022Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1916953000
CY2022Q4	us-gaap	Assets Assets	2259879000
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1833435000
CY2022	mfin	Return On Average Assets Percentage ReturnOnAverageAssetsPercentage	0.024
CY2022	mfin	Percentage Of Return On Average Stockholders Equity PercentageOfReturnOnAverageStockholdersEquity	0.1492
CY2022	mfin	Percentage Of Return On Average Equity PercentageOfReturnOnAverageEquity	0.1374
CY2022	mfin	Interest Yield InterestYield	0.107
CY2022	mfin	Net Interest Margin NetInterestMargin	0.0873
CY2022	mfin	Net Interest Margin Net Of Allowance Percentage NetInterestMarginNetOfAllowancePercentage	0.0905
CY2022	mfin	Reserve Coverage Ratio ReserveCoverageRatio	0.0333
CY2022	mfin	Delinquency Status DelinquencyStatus	0.0047
CY2022	mfin	Chargeoffs To Loans Percentage ChargeoffsToLoansPercentage	0.0096
CY2021	mfin	Interest Income Expense Operating InterestIncomeExpenseOperating	158966000
CY2021	mfin	Interest Expense Net InterestExpenseNet	31140000
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	127826000
CY2021	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	4622000
CY2021	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	123204000
CY2021	mfin	Income From Sponsorship And Race Winnings IncomeFromSponsorshipAndRaceWinnings	12567000
CY2021	mfin	Race Team Related Expense RaceTeamRelatedExpense	9559000
CY2021	us-gaap	Other Income OtherIncome	18999000
CY2021	mfin	Non Interest Expense Income NonInterestExpenseIncome	63340000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	81871000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24217000
CY2021	us-gaap	Profit Loss ProfitLoss	57654000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3546000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	54108000
CY2021Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1488924000
CY2021Q4	us-gaap	Assets Assets	1873057000
CY2021Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	1478001000
CY2021	mfin	Return On Average Assets Percentage ReturnOnAverageAssetsPercentage	0.0333
CY2021	mfin	Percentage Of Return On Average Stockholders Equity PercentageOfReturnOnAverageStockholdersEquity	0.2124
CY2021	mfin	Percentage Of Return On Average Equity PercentageOfReturnOnAverageEquity	0.1764
CY2021	mfin	Interest Yield InterestYield	0.1108
CY2021	mfin	Net Interest Margin NetInterestMargin	0.0891
CY2021	mfin	Net Interest Margin Net Of Allowance Percentage NetInterestMarginNetOfAllowancePercentage	0.0925
CY2021	mfin	Reserve Coverage Ratio ReserveCoverageRatio	0.0337
CY2021	mfin	Delinquency Status DelinquencyStatus	0.0028
CY2021	mfin	Chargeoffs To Loans Percentage ChargeoffsToLoansPercentage	0.0089
CY2023	mfin	Employment Agreement Description EmploymentAgreementDescription	Employment agreements expire at various dates through 2027
CY2023Q4	mfin	Employment Agreements Future Minimum Payments Due EmploymentAgreementsFutureMinimumPaymentsDue	9900000
CY2023Q4	mfin	Employment Agreements Future Minimum Payments Due Current EmploymentAgreementsFutureMinimumPaymentsDueCurrent	4259000
CY2023Q4	mfin	Employment Agreements Future Minimum Payments Due In Two Years EmploymentAgreementsFutureMinimumPaymentsDueInTwoYears	2547000
CY2023Q4	mfin	Employment Agreements Future Minimum Payments Due In Three Years EmploymentAgreementsFutureMinimumPaymentsDueInThreeYears	2161000
CY2023Q4	mfin	Employment Agreements Future Minimum Payments Due In Four Years EmploymentAgreementsFutureMinimumPaymentsDueInFourYears	900000
CY2023Q4	mfin	Employment Agreements Future Minimum Payments Due Thereafter EmploymentAgreementsFutureMinimumPaymentsDueThereafter	0
CY2023Q4	mfin	Employment Agreements Future Minimum Payments Due EmploymentAgreementsFutureMinimumPaymentsDue	9867000
CY2023Q4	us-gaap	Other Commitment OtherCommitment	0
CY2023	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	-300000
CY2022	mfin	Net Change In Unrealized Gains Losses Net Of Tax NetChangeInUnrealizedGainsLossesNetOfTax	-4400000
CY2018Q4	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	25300000
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0

Files In Submission

Name	View Source	Status
0000950170-24-027942-index-headers.html	Edgar Link	pending
0000950170-24-027942-index.html	Edgar Link	pending
0000950170-24-027942.txt	Edgar Link	pending
0000950170-24-027942-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img175641427_0.jpg	Edgar Link	pending
img89325101_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mfin-20231231.htm	Edgar Link	pending
mfin-20231231.xsd	Edgar Link	pending
mfin-ex10_35.htm	Edgar Link	pending
mfin-ex21_1.htm	Edgar Link	pending
mfin-ex23_1.htm	Edgar Link	pending
mfin-ex31_1.htm	Edgar Link	pending
mfin-ex31_2.htm	Edgar Link	pending
mfin-ex32_1.htm	Edgar Link	pending
mfin-ex32_2.htm	Edgar Link	pending
mfin-ex97_1.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
mfin-20231231_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MFIN
MEDALLION FINANCIAL CORP Stock $mfin

2024 Q1 Form 10-K Financial Statement

#000095017024027942 Filed on March 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFIN MEDALLION FINANCIAL CORP Stock $mfin

2024 Q1 Form 10-K Financial Statement

#000095017024027942 Filed on March 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MFIN
MEDALLION FINANCIAL CORP Stock $mfin